Filing Flows › BioScience Health Innovations (BHIC) › Q2 2026 › vs Q2 2025
BioScience Health Innovations (BHIC) Q2 2026 vs Q2 2025 (year over year)
BioScience Health Innovations's revenue fell $721K (-41%) from $1.8M in Q2 2025 to $1.0M in Q2 2026.
BioScience Health Innovations, Q2 2026: revenue $1.0M (-41% year over year), operating margin -21.0%, net loss $186K, operating cash flow −$542K. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $1.0M | $1.8M | −$721K | -41% |
| Income tax benefit | $32K | $0 | $32K | — |
| Net loss | $186K | −$458K | $643K | — |
| Costs & expenses | $1.3M | $1.8M | −$503K | -29% |
| Operating costs | $1.3M | $1.3M | −$46K | -4% |
| Cost of revenue | $377K | $683K | −$306K | -45% |
| Research & development | $71K | $9K | $61K | +664% |
| Other operating costs | $3K | $67K | −$65K | -96% |
| Operating cash sources | $542K | −$285K | $827K | — |
| Cash used in operations | $542K | −$285K | $827K | — |
| Net loss absorbed | $186K | −$458K | $643K | — |
| Working capital & other | $356K | $173K | $183K | +106% |
Questions
How much did BioScience Health Innovations's revenue grow year over year in Q2 2026?
BioScience Health Innovations's revenue fell $721K (-41%) from $1.8M in Q2 2025 to $1.0M in Q2 2026.